In differentiated thyroid cancer (DTC), including papillary and follicular carcinomas, the sodium iodide symporter is expressed similar to normal thyroid tissue, allowing for the uptake of radioactive ...

Alphaf-001 is under clinical development by Alpha Fusion and currently in Phase I for Follicular Thyroid Cancer. According to GlobalData, Phase I drugs for Follicular Thyroid Cancer have a 100% phase ...

Alphaf-001 is under clinical development by Alpha Fusion and currently in Phase I for Papillary Thyroid Cancer. According to GlobalData, Phase I drugs for Papillary Thyroid Cancer have a 100% phase ...

State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, ...

This popped up in the discussion about the incorrect license being applied, but I don't want to lose it. So, this: 5b7314a where rather than forking a repo, you instead copy/paste it wholesale into ...

Note: If you don't want all resources to be included just remove the elements from the list above. If you would like to exclude all repositories and resources just add a single element "all" to the ...

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...

TOKYO--(BUSINESS WIRE)-- Sumitomo Heavy Industries, Ltd. (“SHI”) (TOKYO:6302) (Head Office: Shinagawa-ku, Tokyo, President and CEO: Shinji Shimomura) announced ...

Of all the elements in the periodic table, two have always struck me as alluringly mysterious: francium and astatine. There are more elusive elements than these, of course. But somehow superheavies ...

Radioactive iodine has been used for treatment of thyroid cancer. However, some thyroid tumors become resistant to iodine treatment. A research team used a large accelerator to produce sodium astatide ...

Osaka, Japan – For many years, radioactive iodine which emits beta rays has been used for treatment of thyroid cancer. Generally, 5-year survival rates may exceed 90%. However, some thyroid tumors ...

For many years, radioactive iodine which emits beta rays has been used for treatment of thyroid cancer. Generally, 5-year survival rates may exceed 90%. However, some thyroid tumors become resistant ...